Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).
April 28, 2024
Share
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million on March 28, 2024. Transaction has been financed through own funds or self-raised funds. Baoding Shoujun Technology Co., Ltd. reported Total assets worth CNY 54.5 billion, EBIT of CNY 7.6 billion, Net Income of CNY 1.5 billion and Total Common equity of CNY 196 million on December 31, 2023. Tianjin Ringpu Bio-Technology's board of director's approved the transaction.
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) on April 29, 2024.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).